Response to: Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer et al
- ,
- Maximilian F. Konig,
- Peter Korsten,
- Francis Berenbaum,
- Alfred Hyoungju Kim,
- Jeffrey A. Sparks
- ,
- Universidad Científica del Sur,
- Johns Hopkins University,
- University Medical Center Göttingen,
- Sorbonne Université,
- Washington University in Saint Louis
Research Output:
Contribution to journal
Letter
Peer-review
Open access
Publication Information
Output type
Research Output:
Contribution to journal
Letter
Peer-reviewOriginal language
EnglishArticle number
e162Journal (Volume, Issue Number)
Annals of the Rheumatic Diseases (Volume 81, Issue 9)Publication milestones
- Accepted/In press - 2020
- Published - 01/09/2022
Publication status
Published - 01/09/2022
ISSN
0003-4967Publication IDs
- Scopus: 85092521656
- PubMed: 32759257
Funding Details
Competing interests PK reports personal fees from GlaxoSmithKline, Sanofi-Aventis, Pfizer, Abbvie, Novartis Pharma, Eli Lilly and Bristol-Myers Squibb. FB reports personal fees from Boehringer, Bone Therapeutics, Expanscience, Galapagos, Gilead, GSK, Merck Sereno, MSD, Nordic, Novartis, Pfizer, Regulaxis, Roche, Sandoz, Sanofi, Servier, UCB, Peptinov, TRB Chemedica and 4P Pharma. AHK reports grants from National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and Rheumatology Research Foundation and personal fees from Exagen Diagnostics, Inc. and GlaxoSmithKline. Drs Liew and Graef have disclosed no conflicts of interest or competing interests. JAS reports grants from NIH/ NIAMS/National Institute of Allergy and Infectious Diseases/Autoimmune Centers of Excellence, the Rheumatology Research Foundation, the Brigham Research Institute, and the R. Bruce and Joan M. Mickey Research Scholar Fund as well as personal fees from Bristol-Myers Squibb, Gilead, Inova, Janssen and Optum.
FundersFunding numbers
Autoimmune Centers of Excellence
-NIH
-NIAID
-NIAMS
T32AR048522
GSK
-Gilead Sciences
-RRF
-BRI
-Publication metrics
PlumX, opens in new tab
Captures
45
Mentions
1